AI-Powered personalized care could transform opioid addiction treatment
NCT ID NCT07011758
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to create personalized treatment plans for people with opioid use disorder by using machine learning to find the best sequence of medications and behavioral therapy. Researchers will test these plans in a small pilot study with 75 adults to see if they are feasible and acceptable in real-world clinics. The goal is to reduce overdose risk and improve recovery outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
medication for opioid use disorder and psychotherapy
What this could lead to
If successful, this could lead to more effective, personalized treatment plans for opioid use disorder that reduce overdose risk and improve recovery.
What could go wrong
This is a small, early-stage feasibility trial with only 75 participants, so results may not apply broadly. The exact treatments are not yet finalized, and the study is not yet recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Discovery Behavioral Health
Irvine, California, 92612, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••